Treatment of disorders of the nervous system

Details for Australian Patent Application No. 2004271804 (hide)

Owner NeuroNova AB

Inventors Lindquist, Per?

Agent Cullens

Pub. Number AU-B-2004271804

PCT Pub. Number WO2005/025553

Priority 60/502,386 12.09.03 US

Filing date 10 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 6 January 2011

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/025553 Priority application(s): WO2005/025553

22 June 2006 Amendment Made

  The nature of the amendment is: Amend the invention title to read Treatment of Disorders of the Nervous System

6 January 2011 Application Accepted

  Published as AU-B-2004271804

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004271805-Treatment of gastroparesis and nonulcer dyspepsia with GABAb agonists

2004271800-Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors